Skip to main content
Menu

AlphaLISA Human ApoE Detection Kit, 500 Assay Points

The AlphaLISA™ Human ApoE enables the quantitative determination of Apolipopriein E (ApoE) in cell culture media or serum using a homogeneous (no-wash steps, no separation steps) assay. The assay shows minimum cross-reactivity with ApoA1, ApoB, and ApoCIII.

Feature Specification
Application Protein Quantification
Dynamic Range 11 - 300,000 pg/mL  
Limit of Detection 11 pg/mL  
Limit of Quantification 37 pg/mL  
Sample Volume 5 µL

The AlphaLISA™ Human ApoE enables the quantitative determination of Apolipopriein E (ApoE) in cell culture media or serum using a homogeneous (no-wash steps, no separation steps) assay. The assay shows minimum cross-reactivity with ApoA1, ApoB, and ApoCIII.

Product variants
Unit Size: 100 assay points
Part #:
AL395HV
List price
USD 1,053.00
Your online price:
Unit Size: 500 assay points
Part #:
AL395C
List price
USD 3,160.00
Your online price:
Unit Size: 5,000 assay points
Part #:
AL395F
List price
USD 31,675.00
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

Formats:

  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 100 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Features:

  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

Apolipoprotein E (ApoE) is produced in the liver, brain, kidneys, and spleen. ApoE is mostly found in the intermediatedensity lipoproteins. A critical component of triglyceride-rich lipoproteins, it transports lipoproteins, fat-soluble vitamins, and cholesterol into the tissues and then into the blood. This protein is initially recognized for its importance in lipoprotein metabolism and cardiovascular disease. Recently, ApoE has been shown to be involved in Alzheimer's disease, immunoregulation, and cognition. This kit is designed to detect ApoE in serum, plasma, cell culture supernatants, and cell lysates.

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

How it works

Principle of the AlphaLISA assay

The AlphaLISA assay is based on an AlphaLISA sandwich immunoassay involving a biotinylated anti-analyte antibody bound to Streptavidin-coated AlphaLISA Donor beads and an anti-analyte antibody conjugated to AlphaLISA Acceptor beads. Both antibodies are directed against the analyte of interest. In the presence of the target, both antibodies bind to analyte and the beads come into proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer within the Acceptor beads, resulting in emission with λmax at 615 nm. The intensity of the signal is directly proportional to the concentration of analyte present in the sample.

Assay Principle AlphaLISA

 

Protocol of the AlphaLISA assay

The AlphaLISA assay can be run in a 96- or 384-well detection plate (50 µL final). As described here, samples or standards are dispensed directly into the assay plate for the detection of the analyte of interest by AlphaLISA reagents. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

Protocol of the AlphaLISA human CCL17 assay

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
11 - 300,000 pg/mL  
Limit of Detection
11 pg/mL  
Limit of Quantification
37 pg/mL  
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Blue Ice
Target
ApoE
Target Class
Biomarkers
Target Species
Human
Technology
Alpha
Therapeutic Area
Central Nervous System
Unit Size
500 assay points

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Whitepaper Icon
Whitepaper
An overview of atherosclerosis

Atherosclerosis pathogenesis, cellular actors, and pathways

Atherosclerosis is a common condition in which arteries harden and...

Loading...

Scroll Icon

Revvity AI Assistant Beta